TAIKO PHARMACEUTICAL CO., LTD.
4574 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 吹田市内本町三丁目３４番１４号
- Website:
- https://www.seirogan.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Taiko Pharmaceutical Co., Ltd. is a renowned Japanese company with a legacy spanning over 100 years, specializing in medical and infection control products. With a strong focus on gastrointestinal medications, Taiko has established itself as a trusted name in healthcare. The company also boasts a leading position in Japan’s airborne disinfectant market. Guided by principles of Independence, Interdependence, and Creativity, Taiko Pharmaceutical is dedicated to enhancing the well-being of customers worldwide. Committed to innovation, the company invests significantly in research and development to ensure the delivery of high-quality products that meet the evolving needs of the healthcare sector.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-01 08:45 |
Inside Information Statement
臨時報告書
|
Japanese | 22.1 KB | |
| 2025-03-28 07:36 |
Inside Information Statement
臨時報告書
|
Japanese | 19.1 KB | |
| 2025-03-28 07:35 |
Internal Control over Financial Reporting
内部統制報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 22.1 KB | |
| 2025-03-28 07:33 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-03-28 07:32 |
Annual Report
有価証券報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 1011.8 KB | |
| 2024-08-09 08:34 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-08-09 08:33 |
Interim Report
半期報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 210.9 KB | |
| 2024-05-10 08:37 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-05-10 08:35 |
Quarterly Report
四半期報告書－第79期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 164.9 KB | |
| 2024-04-01 08:14 |
Inside Information Statement
臨時報告書
|
Japanese | 23.7 KB | |
| 2024-03-28 07:30 |
Internal Control over Financial Reporting
内部統制報告書－第78期(2023/01/01－2023/12/31)
|
Japanese | 22.1 KB | |
| 2024-03-28 07:28 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-03-28 07:26 |
Annual Report
有価証券報告書－第78期(2023/01/01－2023/12/31)
|
Japanese | 1.1 MB | |
| 2024-02-09 07:36 |
Inside Information Statement
臨時報告書
|
Japanese | 19.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
| ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
|
Astellas Pharma Inc. | Japan | 4503 | |
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biofarm S.A. | Romania | BIO | |
|
Biogened Spolka Akcyjna | Poland | BGD |